Condition: Meningioma · Meningioma Atypical · Anaplastic Meningioma · Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The investigators plan to collect clinical and molecular data, including ICH, PCR, NGS and methylome, from patients operated on for grade 2 or grade 3 meningioma. The purpose of the study is to identify reliable and easy-to-assess predictive factors for recurrence and survival after surgery.
This description comes directly from the study's public registry record.
Alessandro Olivi, MD · +39 06 3015 4120 · alessandro.olivi@policlinicogemelli.it
Rina Di Bonaventura, MD · +39 06 3015 1 · rina.dibonaventura@guest.policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario A. Gemelli IRCCS | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05793034